Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Publication year range
1.
J Physiol Pharmacol ; 56(2): 233-45, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15985705

ABSTRACT

Estrogens exert protective effects against neurotoxic changes induced by over-activation of ionotrophic glutamate receptors, whereas little is known about their interaction with changes mediated by metabotropic glutamate receptors. We evaluated effects of estrone on quisqualate (QA)-induced toxicity in neuronal cell cultures on 7 and 12 day in vitro (DIV). Twenty four hour exposure to QA (150 microM and 300 microM) significantly decreased cell survival in 7 day old cultures, but the 12 day old cultures were more resistant to its toxicity. DNQX (10 microM), an AMPA/kainate receptor antagonist, partly attenuated the toxic effects of QA, whereas LY 367 385 (100 microM), a selective mGluR1a antagonist, completely reversed the above effect. QA did not activate, but suppressed spontaneous caspase-3-like activity. Estrone (100 nM and 500 nM) attenuated QA-mediated neurotoxic effects independently of estrogen receptors, as indicated with ICI 182, 780 and without affecting the caspase-3-like activity. At early stage of development in vitro (7 DIV) toxic effects of QA were more profound and mediated mainly by metabotropic glutamate receptors of group I, whereas later (12 DIV) they were mediated mostly by ionotropic AMPA/kainate receptors. The toxic effects of QA were partly accompanied by anti-apoptotic action against spontaneous caspase-3-like activity, possibly due to modulation of neuronal plasticity.


Subject(s)
Estrone/pharmacology , Neocortex/drug effects , Quisqualic Acid/toxicity , Animals , Apoptosis/drug effects , Caspase 3 , Caspases/metabolism , Cell Survival/drug effects , Cells, Cultured , Neocortex/cytology , Quinoxalines/pharmacology , Rats
2.
J Physiol Pharmacol ; 52(3): 437-46, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11596861

ABSTRACT

Estrogens possess neuroprotective and antiapoptotic properties, however, the issue of involvement of estrogen receptors (ER)-dependent genomic pathway in these effects still remains controversial. Moreover, the majority of data on antiapoptotic effects of estrogens concern non-neuronal cells. In the present study we compared effects of the potent ER agonist, estradiol-17beta (E2), and its metabolite with a weak affinity for ER, estriol, on the neurotoxicity induced by high (1 and 5 mM) NMDA concentrations and on the apoptosis induced by low (0.1 mM) concentration of NMDA in rat primary cortical neurons. The obtained data showed that 24-hour exposure of cortical neurons to NMDA (0.1-5 mM) resulted in a dose-dependent increase in LDH level. Twenty four-hour pretreatment with estriol (100 nM and 500 nM) reduced the NMDA (1 and 5 mM)-induced toxicity by 16-26%, while estradiol-17beta (500 nM) reduced NMDA (5 mM)- induced toxicity by 14%. Twenty four hour exposure of cortical neurons to NMDA (0.1 mM) resulted in decrease of the level of antiapoptotic protein - Bcl-2 by 60% and increased the number of apoptotic cells by 50% compared to the control. Twenty four hour pretreatment with estradiol-17beta or estriol (100 and 1000 nM) prevented the NMDA-induced apoptotic changes. The specific estrogen receptor antagonist ICI 182,780 (100 nM) had no effect alone and did not antagonize the effects of estrogens on NMDA-induced toxicity as well as on changes in Bcl-2 level. The higher efficacy of estriol, together with the fact that the specific ER receptor antagonist, ICI 182,780, did not inhibit the above-described effects support the hypothesis about a nongenomic mechanism of the anti-NMDA action of estrogens.


Subject(s)
Apoptosis/drug effects , Cerebral Cortex/drug effects , Estradiol/pharmacology , Estriol/pharmacology , N-Methylaspartate/toxicity , Neuroprotective Agents/pharmacology , Adrenocorticotropic Hormone/metabolism , Adrenocorticotropic Hormone/pharmacology , Animals , Cells, Cultured , Cerebral Cortex/pathology , Female , L-Lactate Dehydrogenase/metabolism , Proto-Oncogene Proteins c-bcl-2/analysis , Rats
3.
Wiad Lek ; 51(1-2): 64-70, 1998.
Article in Polish | MEDLINE | ID: mdl-9608834

ABSTRACT

Nectrotizing fasciitis is a mixed infection of skin and subcutaneous tissue with a characteristic clinical and pathological appearance. Necrotizing soft tissue infections, caused by aerobic, anaerobic and mixed bacterial flora are an increasing problem in medical and surgical practice. The apparently wide variety of these infections is systematized. Etiology and bacteriology are discussed, as the role of surgery, antibiotics and hyperbaric chamber in the treatment of the infections. Early and radical surgical excision of all affected tissue is the treatment of choice. Adjuvant hyperbaric oxygen appears to be important in refractory progressive bacterial gangrene. A combination of hyperbaric oxygen, surgical treatment and antibiotics gives the lowest mortality and morbidity in gas gangrene compared with other treatment modifications. Extensive clinical experience shows the efficacy of these treatment protocols.


Subject(s)
Dermatitis/classification , Dermatitis/therapy , Fasciitis, Necrotizing/classification , Fasciitis, Necrotizing/therapy , Soft Tissue Infections/classification , Soft Tissue Infections/therapy , Anti-Bacterial Agents/therapeutic use , Dermatitis/microbiology , Fasciitis, Necrotizing/microbiology , Humans , Hyperbaric Oxygenation , Muscles/microbiology , Muscles/pathology , Necrosis , Skin/microbiology , Skin/pathology , Soft Tissue Infections/microbiology
7.
Z Gesamte Inn Med ; 32(18): suppl 286-8, 1977 Sep 15.
Article in German | MEDLINE | ID: mdl-595709

ABSTRACT

A computer programme for the digitalis therapy developed by us was tested in 282 patients with heart insufficiency. It helps to control the course of the therapy, to establish the optimum fully effective dose of the individually determined glycoside sensitivity and to decrease significantly the danger of an overdosage.


Subject(s)
Digitalis Glycosides/therapeutic use , Electronic Data Processing , Computers , Germany, East , Heart Failure/drug therapy , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...